Antroposofische Gezondheidszorg onderzoek

Projects in preparation

Anthroposophic mental healthcare

As a follow-up to the development of the healthcare programme 'Depression' and the current changes in mental healthcare, a project is being developed in collaboration with doctors, therapists and Lievegoed, the anthroposophic psychiatric hospital. The aim is to deploy practical research to continue the development, testing and profiling of AH mental healthcare. 

CiSAR

The CiSAR Study is examining the effects and safety of Citrus/Cydonia comp.® solution for injection in patients with seasonal allergic rhinitis (hay fever) caused by grass pollen. This is a randomised, double-blind, placebo-controlled, comparative clinical trial with three parallel treatment groups.

Courses in casuistic research methods

The development of two 'how to do' courses about the use of casuistic methods in clinical practice (1) and research (2).

Effect of rhythmic massage on symptoms of fatigue in women with breast cancer

A placebo-controlled, randomised trial in which the effects of rhythmical massage and sham massage on cancer-related fatigue are compared.

Factsheets/ e-books on anthroposophic therapies

The factsheets present a schematic overview of the scientific status of the specific AH professional group. The long-term aim is to produce digital factsheets.

Measles study - 2nd phase

Follow-up study on the vaccination grades of 'anthroposophic children'.

ROM AH medicines

Many anthroposophic medicines lack sufficient evidence of their safety and efficacy. In close collaboration with the NVAA [Netherlands Society for Anthro sophical Physicians], the professorship is developing a routine outcome monitoring system that will document at a basic level the safety and effects of medicines for specific indications. 

External therapy for arthritis in the knee

The project aims to demonstrate the efficacy of external therapy with ginger patches in patients with knee osteo arthritis (OA). The project will contribute to finding new and/or additional therapies for OA and minimise the risk of side effects, as experienced by the use of conventional pharmacological treatment.